Updated: Aug 31, 2020
'QB3 Entrepreneur Discussion Series -- Monthly Discussions on Moving Bioscience Innovations to the Market' ED DIAO & ZOE QUAN Orthopedic surgeon & CEO, Socorro Medical/President, Qingchu Thinking Startups as a Team Sport
"Socorro Medical, Inc. is a medical device venture dedicated to developing transformative endoscopic devices for surgeons to improve patient outcomes. We will share some of the lessons Socorro is learning about the challenges confronting a start up on the road to commercialization, starting with identifying the problem to be solved, and the value of getting suitable help early and often from multiple sources, some of which come from unlikely directions. Speaker Bios Dr. Edward Diao is the founder and CEO of Socorro Medical, Inc. He is a leading orthopedic surgeon with substantial hands-on experience and customer insight. He is a successful clinician, scientist, educator, and innovator, and has maintained leadership positions in major orthopedic and hand surgery societies for over 24 years. Dr. Diao is professor emeritus of Orthopedic Surgery and Neurosurgery at UCSF, where he was chief of Hand, Upper Extremity, and Microvascular Surgery for 13 years. He has been the PI on multiple NIH RO1 and SBIR grants. He is currently on the SAB of NanoNerve, Inc., and founder of EndoOrthopaedics, Inc. which is a QB3 incubator company.
Dr. Zoe Quan is president of Qingchu Thinking, LLC, a strategy evaluation firm that combines strategy, international business, and assessing technologies for their growth potential to help companies think through where they are, where they think they want to be, and what they need to do to get there. She helps ventures see patterns among seemingly unrelated pieces of information to home in on key issues, and translate vision into executable strategies. She has held senior leadership positions with large multinationals as well as entrepreneurial ventures in Asia, Europe, and North America, and is skilled at all aspects of product management, including strategy, product development, business plan development and execution, and P&L responsibility. What quickens her blood is translating between the language of business and the language of technologies to unleash the commercial potential of innovative research. " *For more information on QB3 visit: http://www.qb3.orgDr. Diao Speaks on "Startups as a Team Sport"